These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16494107)

  • 1. Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease.
    Guidi L; De Franco A; De Vitis I; Armuzzi A; Semeraro S; Roberto I; Papa A; Bock E; Gasbarrini G; Fedeli G
    Eur Rev Med Pharmacol Sci; 2006; 10(1):23-6. PubMed ID: 16494107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease.
    Van Assche G; Herrmann KA; Louis E; Everett SM; Colombel JF; Rahier JF; Vanbeckevoort D; Meunier P; Tolan D; Ernst O; Rutgeerts P; Vermeire S; Aerden I; Oortwijn A; Ochsenkühn T
    J Crohns Colitis; 2013 Dec; 7(12):950-7. PubMed ID: 23411006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of inflammatory and fibrotic stenoses in patients with Crohn's disease using contrast-enhanced ultrasound and computerized algorithm: a pilot study.
    Schirin-Sokhan R; Winograd R; Tischendorf S; Wasmuth HE; Streetz K; Tacke F; Trautwein C; Tischendorf JJ
    Digestion; 2011; 83(4):263-8. PubMed ID: 21273775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn's disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment.
    Quaia E; Migaleddu V; Baratella E; Pizzolato R; Rossi A; Grotto M; Cova MA
    Eur J Radiol; 2009 Mar; 69(3):438-44. PubMed ID: 19070446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound of the small bowel in Crohn's disease.
    Quaia E
    Abdom Imaging; 2013 Oct; 38(5):1005-13. PubMed ID: 23728306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasonography in Crohn's disease.
    De Pascale A; Garofalo G; Perna M; Priola S; Fava C
    Radiol Med; 2006 Jun; 111(4):539-50. PubMed ID: 16779540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced ultrasonography (CEUS) vs. MRI of the small bowel in the evaluation of Crohn's disease activity.
    Malagò R; D'Onofrio M; Mantovani W; D'Alpaos G; Foti G; Pezzato A; Caliari G; Cusumano D; Benini L; Pozzi Mucelli R
    Radiol Med; 2012 Mar; 117(2):268-81. PubMed ID: 22271005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease.
    Szabó D; Kökönyei G; Arató A; Dezsőfi A; Molnár K; Müller KE; Lakatos PL; Papp M; Lovász BD; Golovics PA; Cseh A; Veres G
    J Crohns Colitis; 2014 Aug; 8(8):747-55. PubMed ID: 24434181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sonographic lesion index for Crohn's disease helps monitor changes in transmural bowel damage during therapy.
    Zorzi F; Stasi E; Bevivino G; Scarozza P; Biancone L; Zuzzi S; Rossi C; Pallone F; Calabrese E
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2071-7. PubMed ID: 24813174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the ultrasound longitudinal natural history of newly diagnosed pediatric small bowel Crohn disease treated with infliximab and infliximab-azathioprine combination therapy.
    Dillman JR; Dehkordy SF; Smith EA; DiPietro MA; Sanchez R; DeMatos-Maillard V; Adler J; Zhang B; Trout AT
    Pediatr Radiol; 2017 Jul; 47(8):924-934. PubMed ID: 28421251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of bowel wall vascularisation in Crohn's disease with contrast-enhanced ultrasound and perfusion analysis.
    Girlich C; Jung EM; Iesalnieks I; Schreyer AG; Zorger N; Strauch U; Schacherer D
    Clin Hemorheol Microcirc; 2009; 43(1-2):141-8. PubMed ID: 19713608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of infliximab on small bowel stenoses in patients with Crohn's disease.
    Pallotta N; Barberani F; Hassan NA; Guagnozzi D; Vincoli G; Corazziari E
    World J Gastroenterol; 2008 Mar; 14(12):1885-90. PubMed ID: 18350627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn's disease.
    Kupcová V; Turecký L; Detková Z; Príkazská M; Keleová A
    Physiol Res; 2003; 52(1):89-93. PubMed ID: 12625812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease.
    Van den Brande JM; Koehler TC; Zelinkova Z; Bennink RJ; te Velde AA; ten Cate FJ; van Deventer SJ; Peppelenbosch MP; Hommes DW
    Gut; 2007 Apr; 56(4):509-17. PubMed ID: 17082252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease.
    Bortlik M; Duricova D; Malickova K; Machkova N; Bouzkova E; Hrdlicka L; Komarek A; Lukas M
    J Crohns Colitis; 2013 Oct; 7(9):736-43. PubMed ID: 23200919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I.
    Reinisch W; Wang Y; Oddens BJ; Link R
    Aliment Pharmacol Ther; 2012 Mar; 35(5):568-76. PubMed ID: 22251435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn's disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy.
    Parente F; Greco S; Molteni M; Anderloni A; Sampietro GM; Danelli PG; Bianco R; Gallus S; Bianchi Porro G
    Gut; 2004 Nov; 53(11):1652-7. PubMed ID: 15479688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.